Sites STREAM
-
How State-Of-The-Art Clinical Trial Mobile Vision Clinics Work
3/11/2025
Are you seeking a non-traditional option to complete the eye exams necessary for your ocular clinical trials? A mobile clinic may be the solution you're looking for.
-
Reducing The Travel Burden For Patients - The Benefits Of Mobile Vision Clinics
3/11/2025
Travel to trial sites can be a major hurdle for patients considering participation, but mobile vision clinics are providing a solution to improve accessibility, capacity, and patient enrollment.
-
Tailored Sponsor Engagement Key To Unlocking Site Network Efficiency
4/25/2025
Karri Venn, VP site advocacy and mentorship at SCRS, emphasized the importance of sponsors recognizing the structure and capabilities of larger site networks.
-
An Overview Of Health Canada's CTA Process
10/24/2023
Experience expedited timelines by conducting trials in Canada. Our expertise in navigating Health Canada's CTA process ensures smooth and efficient approvals.
-
Harnessing The Potential Of Patient-Level Data In Clinical Trials
6/19/2024
Join our panel of industry leaders as they explore innovative methods and best practices for incorporating fully consented patient data in clinical trials.
-
An Introduction To One Home for Sites™
4/18/2024
This on-demand webinar provides a thorough overview of why IQVIA Technologies is building One Home for Sites, how it works, and who should participate.
-
Why Relationship-Building Is The Hardest Part Of Site Success
4/25/2025
Site owner Devora Henderson of Elevate Clinical Research reflected on her experience launching two site networks.
-
Trends In Sponsor-Of-Choice Initiatives: Consolidating Site Payments
5/5/2023
Listen in as leaders from Bristol Myers Squibb, CenExel Centers of Excellence, and IQVIA Technologies discuss the importance of providing a consistent clinical trial payment experience to sites.
-
Sky-High Inflation And The Great Resignation: The Impact On Clinical Site Budgeting
11/17/2022
When it comes to negotiating budgets for a clinical trial, sponsors, CROs and sites all have the same goal: to run the study. Yet just like most business relationships, the conflict comes in what defines a fair price for services rendered. Now, with inflation at its highest rate in four decades and attrition rates at clinical research sites exceeding most industries, developing fair marketing value (FMV) for investigator grants is more contentious than ever.
-
How Sites Are Often Evaluated By Sponsors
4/25/2025
Adam Kinsey described how sponsor-site partnerships at Merck typically start small. Sites are evaluated not only on enrollment but on predictability and communication throughout a study.